Check back on or after September 15th for Chairman Gene Williams presentation at the HC Wainwright 22nd Annual investment Conference.
- ProMIS Neurosciences’ perspective on aducanumab advancement: is approval likely? October 21, 2020
- ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference October 13, 2020
- ProMIS Neurosciences to develop multivalent vaccine for Alzheimer’s disease September 22, 2020